NIH-funded research Career grant

Exploring how sugar molecules on proteins affect skin cancer

Official title: Functional Landscape of Glycosylation in Skin Cancer

Funded at Rockefeller University · NIH-10772110 · Data updated 2026-11-12

This study is looking at how sugar molecules attached to proteins might affect the growth of squamous cell carcinoma, a common skin cancer, and aims to find new treatment options that could help patients like you.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$178,427
NIH project number5K99CA277591-02
Project IDNIH-10772110 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with squamous cell carcinoma or those at high risk for developing this type of skin cancer.

Less likely to help

Patients with other types of skin cancer or those without any malignancies may not receive direct benefits from this research.

What this research studies

This research investigates the role of glycosylation, a process where sugar molecules attach to proteins, in the development and progression of squamous cell carcinoma (SCC), a common type of skin cancer. Using a mouse model, the study aims to map changes in glycosylation patterns associated with SCC and to identify potential new therapies. The researchers will employ advanced techniques such as microscopy and genetic screening to understand how these sugar modifications influence cancer behavior and treatment responses. Patients may benefit from insights that could lead to innovative treatment strategies targeting glycosylation.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic approaches for treating skin cancer by targeting glycosylation changes.

How similar studies have gone: Other research has shown promising results in understanding glycosylation's role in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Kudelka, Matthew Robert — Rockefeller University
  • Study coordinator: Kudelka, Matthew Robert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.